AmerisourceBergen CEO Must Testify In Opioid Bellwether

Law360 (June 29, 2020, 9:59 PM EDT) -- Virginia Special Master Christopher C. Wilkes on Monday ordered AmerisourceBergen Drug Corp. CEO Steven H. Collis to testify in the second bellwether opioid suit expected to head to trial in federal multidistrict litigation, rejecting the company's arguments taking his video-deposition would be too burdensome.

In a nine-page order, Wilkes rejected the drug distributor's argument that Collis should be shielded from testifying under the so-called apex doctrine, which excuses high-level executives from litigation if they have no unique, personal knowledge of facts in dispute and if the plaintiffs can obtain the information they seek from less burdensome means, such as through written discovery or...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!